Endpoints News identifies 25 biopharma CEOs earning $25M or more in 2025
read at Endpoints ↗Neutral
Endpoints News released a ranking of the highest-paid chief executives in the biopharma sector for 2025.
For the first time in four years the publication raised the minimum compensation threshold from $20 million to $25 million, creating a list of 25 CEOs whose total pay surpassed that level.
The list underscores the concentration of executive compensation at the top of the industry and reflects broader trends in pay across biotech and pharmaceutical companies.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Biopharma's top-paid CEOs of 2025: 25 making $25M+”
read at Endpoints ↗83 words · retrieved Jun 8
comments(0)
5-min edit window · permanent after that